🔎 Trials Near Me

Gara Jalqabaatti › Dhukkuba Kroonii › Texas › Lubbock

Qorannoo klinikaalii Dhukkuba Kroonii Lubbock, TX keessatti

Qorannoo 10 Dhukkuba Kroonii f Lubbock fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Namoota walitti qabaa jiraSadarkaa 2
  • GI Alliance - Lubbock /ID# 283920, Lubbock
  • Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07697456

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Namoota walitti qabaa jiraSadarkaa 3
  • GI Alliance - Lubbock ( Site 0288), Lubbock
  • Caprock Gastro Research ( Site 0293), Lubbock
Umuriin hundi · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Namoota walitti qabaa jiraSadarkaa 3
  • Caprock Gastro Research ( Site 5077), Lubbock
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Namoota walitti qabaa jiraSadarkaa 4
  • West Texas Research Institute, Lubbock
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Lubbock Gastroenterology, Lubbock
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07499232

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • GI Alliance - Lubbock-Site Number: 8400092, Lubbock
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 3
  • GI Alliance - Lubbock-Site Number: 8400092, Lubbock
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Namoota walitti qabaa jiraSadarkaa 4
  • Texas Digestive Disease Consultants Lubbock, Lubbock
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06045754

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Mirador Therapeutics Selected Site, Lubbock
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 12-Bit-2026 · NCT07113522

Qorannoo Dhukkuba Kroonii magaalota biroo keessatti

Qorannoo biroo Lubbock keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.